Fexo 120 mg, 180 mg FC tablets.
PDF Leaflet Revision Date: 16 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of symptoms associated with seasonal allergic rhinitis and chronic idiopathic urticaria.
Dosage (summary)
Adults: 120 mg once daily for SAR; 180 mg once daily for CIU. Renal impairment: 60 mg daily.
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Erythromycin
- Ketoconazole
- Antacids containing aluminium and magnesium
Contraindications
- Hypersensitivity to fexofenadine or excipients
Common side effects
- Drowsiness
- Dizziness
- Headache
- Nausea
Counselling Points
- Avoid alcohol and CNS depressants
- Take antacids 2 hours apart
Serious warnings
- May affect ability to drive or operate machinery
- Caution in cardiovascular disease
Important Disclaimer
The Fexo 120 mg, 180 mg FC tablets. professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
